FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 2151689 · Received July 6, 2011

Report

Report Number
2124215-2011-06068
Event Type
Injury
Date Received
July 6, 2011
Date of Event
April 1, 2011
Report Date
April 1, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

ALL AVAILABLE INFORMATION INDICATES THAT THIS PRODUCT REMAINS IN SERVICE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT ONE DAY POST IMPLANT OF THIS TRANSVENOUS DEFIBRILLATION LEAD, DURING THE POST-OP CHECK, SENSING WAS POOR AND THERE WAS NO CAPTURE AT HIGH OUTPUT. A CHEST X-RAY WAS OBTAINED WHICH REVEALED A POSSIBLE MICRO-DISLODGEMENT. A REVISION PROCEDURE WAS PERFORMED TO REPOSITION THE LEAD. IT WAS NOTED THAT THE PATIENT HAS SEVERE TRICUSPID REGURGITATION. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0181

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention